News
APDN
0.2388
-17.66%
-0.0512
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated fell 9.3% to $369.16 on Wednesday. The company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS guidance. Chicken Soup for the Soul Entertainment, Inc. Shares jumped 136% in the mid-day session.
Benzinga · 7h ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Chicken Soup for the Soul (NASDAQ:CSSE) stock is rocketing more than 68% alongside heavy pre-market trading. Tesla’s stock is surging close to 24% following its latest earnings report. Earnings reports, a reverse stock split and more are the biggest pre- market stock movers.
Investorplace · 13h ago
Applied DNA Sciences Announces 1:20 Reverse Stock Split
TipRanks · 2d ago
Applied DNA announces 1-for-20 reverse stock split
Applied DNA Sciences, Inc. Says it will implement a 1-for-20 stock split of its common stock effective April 25. Shares of APDN rose 4.2% in extended trading. The company says the reverse stock split is intended to regain compliance with minimum bid price requirement.
Seeking Alpha · 2d ago
APPLIED DNA SCIENCES INC - APPLIED DNA COMMON STOCK WILL BEGIN TRADING ON A SPLIT-ADJUSTED BASIS COMMENCING UPON MARKET OPEN ON APRIL 25
Reuters · 2d ago
Applied DNA Announces 1-For-20 Reverse Stock Split, Will Begin Trading On A Split-Adjusted Basis Commencing Upon Market Open On Thursday, April 25, 2024
Applied DNA Sciences, Inc. Will effect a 1-for-20 stock split of its common stock. The reverse stock split will be effective as of 12:01 a.m. Eastern Time on Thursday, April 25, 2024. The Company's common stock will continue to trade on the Nasdaq Capital Market.
Benzinga · 2d ago
Weekly Report: what happened at APDN last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at APDN last week (0408-0412)?
Weekly Report · 04/15 09:55
Weekly Report: what happened at APDN last week (0401-0405)?
Weekly Report · 04/08 09:56
Weekly Report: what happened at APDN last week (0325-0329)?
Weekly Report · 04/01 09:56
Weekly Report: what happened at APDN last week (0318-0322)?
Weekly Report · 03/25 09:58
12 Health Care Stocks Moving In Wednesday's After-Market Session
XTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The company's Q4 earnings report came out 2 days ago. Jaguar Health and Leap Therapeutics were among the gainers.
Benzinga · 03/20 21:34
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
Weekly Report: what happened at APDN last week (0311-0315)?
Weekly Report · 03/18 09:57
Applied DNA Sciences files to sell 11.29M shares of common stock for holders
Applied DNA Sciences files to sell 11.29M shares of common stock for holders. Applied DNA Sciences, Inc. Filed a prospectus related to the proposed resale of shares by the selling stockholders. This prospectus is not an offer to sell these securities.
Seeking Alpha · 03/12 15:58
Weekly Report: what happened at APDN last week (0304-0308)?
Weekly Report · 03/11 09:55
Weekly Report: what happened at APDN last week (0226-0301)?
Weekly Report · 03/04 09:57
Weekly Report: what happened at APDN last week (0219-0223)?
Weekly Report · 02/26 10:02
Applied DNA Sciences (APDN) Price Target Increased by 12.50% to 2.30
NASDAQ · 02/24 07:24
Weekly Report: what happened at APDN last week (0212-0216)?
Weekly Report · 02/19 10:03
More
Webull provides a variety of real-time APDN stock news. You can receive the latest news about Applied Dna Scie through multiple platforms. This information may help you make smarter investment decisions.
About APDN
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.